differences of risk factors attributable to development of CVD in Asian populations, is limited. 3, 7 Atherosclerotic disease is rarely confined to the coronary arteries and thus the CVD risk factors are largely the same as those for coronary heart disease (CHD). 8 In addition to the standard Framingham risk factors of age, sex, diabetes mellitus, smoking, blood pressure, and cholesterol, 9,10 recently developed prediction models showed that CVD risk also relates to parental history of myocardial infarction (MI), inflammatory biomarkers, such as high-sensitivity C-reactive protein (hsCRP), and markers of glycemic control such as Background-A model for predicting cardiovascular disease in Asian populations is limited. Methods and Results-In total, 57 393 consecutive asymptomatic Korean individuals aged 30 to 80 years without a prior history of cardiovascular disease who underwent a general health examination were enrolled. Subjects were randomly classified into the train (n=45 914) and validation (n=11 479) cohorts. Thirty-one possible risk factors were assessed. The cardiovascular event was a composite of cardiovascular death, myocardial infarction, and stroke. In the train cohort, the C-index (95% confidence interval) and Akaike Information Criterion were used to develop the best-fitting prediction model. In the validation cohort, the predicted versus the observed cardiovascular event rates were compared by the C-index and Nam and D'Agostino χ 2 statistics. During a median follow-up period of 3.1 (interquartile range, 1.9-4.3) years, 458 subjects had 474 cardiovascular events. In the train cohort, the best-fitting model consisted of age, diabetes mellitus, hypertension, current smoking, family history of coronary heart disease, white blood cell, creatinine, glycohemoglobin, atrial fibrillation, blood pressure, and cholesterol (C-index =0.757 [0.726-0.788] and Akaike Information Criterion =7207). When this model was tested in the validation cohort, it performed well in terms of discrimination and calibration abilities (C-index=0.760 [0.693-0.828] and Nam and D'Agostino χ 2 statistic =0.001 for 3 years; C-index=0.782 [0.719-0.846] and Nam and D'Agostino χ 2 statistic=1.037 for 5 years). Conclusions-A risk model based on traditional clinical and biomarkers has a feasible model performance in predicting cardiovascular events in an asymptomatic Korean population. (Circ Cardiovasc Qual Outcomes. 2014;7:944-951.)
D uring the past decades, cardiovascular disease (CVD) has rapidly increased in Asian countries and about half of the worldwide burden of CVD is carried in these countries. 1, 2 Therefore, CVD prevention in Asia has been an important issue for world health. 3 In the guideline, tailored approaches by risk stratification of asymptomatic people using global risk scores have become an accepted method for the primary prevention of CVD. 4, 5 However, effectiveness of existing CVD risk models, developed on the basis of the database of Western countries, was rarely validated for Asian populations. 6 In addition, a risk prediction model, considering the race or ethnic glycohemoglobin in diabetics. 11, 12 However, CVD risk prediction models that include these possible biomarkers have not yet been developed for Asian populations.
To address these issues, we developed and validated a risk model to predict global cardiovascular risk using standard risk factors and possible biomarkers in a large cohort of asymptomatic Korean individuals.
Methods

Data Sources
In total, 91 636 consecutive South Korean individuals aged 30 to 80 years who had undergone a general health examination in the Health Screening and Promotion Center at the Asan Medical Center, a 2791-bed tertiary treatment referral hospital located in Seoul, were enrolled between January 2007 and June 2011. Of these, 65 739 (72%) consented to participate. Subjects were excluded if, before the index day, the Health Insurance Review and Assessment Service (HIRA) database indicated that they had a history of CVD (codes I00-99 in the International Classification of Diseases [ICD-10], 10th Revision) or their data were not available in the HIRA database. The HIRA is a quasigovernmental organization that systematically reviews medical fees to minimize the risk of redundant and unnecessary medical services. South Korea has a National Health Insurance system and it is mandatory that all healthcare providers join this system on a fee-for-service basis. 13 Consequently, all National Health Insurance claims are reviewed by the HIRA. 14 For the present study, the HIRA database up until December 2011 was used. This study was conducted by permission of the National Strategic Coordinating Center of Clinical Research and HIRA in Korea. Subjects with angina, MI, stroke, structural heart disease, percutaneous coronary intervention, previous cardiac procedure, or open heart surgery before the index day were also excluded. Thus, 57 393 subjects were finally enrolled ( Figure 1 ). This study was approved by the local Institutional Review Board of the Asan Medical Center, Seoul, Korea. All subjects enrolled in this study provided written informed consent.
The basic demographic data of the subjects were acquired from a database that is maintained by the Health Screening and Promotion Center at Asan Medical Center. Any medical history of angina, MI, stroke, structural heart disease, coronary revascularization, previous cardiac procedure, open heart surgery, hypertension, diabetes mellitus, or hyperlipidemia; family history of CHD; smoking status; physical activity; and education status were collected from a systemized questionnaire before general health examination. A family history of CHD was defined as CHD occurring in a first-degree relative of any age. Physical activity was classified according to the exercise frequency (>5 days, 3-5 days, <3 days, and none) and duration (>1 hour, 20 minutes to 1 hour, and <20 minutes), respectively. Education status was also classified into 4 levels (>college or university graduate, college or university graduate, high school graduate, and ≤middle school graduate). In the general health examination, height, body weight, body mass index, waist circumference, and blood pressure were measured and an ECG was performed. Furthermore, complete blood count, erythrocyte sedimentation rate, fasting plasma glucose, glycohemoglobin, uric acid, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglyceride, blood urea nitrogen, serum creatinine, and hsCRP concentrations were measured on the day of the examination after a fast of ≥12 hours. The aspirin or statin medication history was obtained from the HIRA database.
WHAT IS KNOWN
• The purpose of risk prediction model is to identify high-risk individuals and to improve a prognosis through aggressive interventions in these subjects. However, a model for predicting cardiovascular disease in Asian populations is limited.
WHAT THE STUDY ADDS
• A cardiovascular risk model, based on both standard risk factors and biomarkers, was developed and showed a feasible model performance for predicting events in a large cohort consisting of asymptomatic Korean individuals undergoing a general health examination. • East Asian populations have similar risk factors for cardiovascular disease and a specific characteristic of higher incidence of mortality from stroke than coronary heart disease. Therefore, this model has the potential to identify East Asian individuals at high risk. However, the application of this proposed risk model should be evaluated in additional studies. 
Outcome
The CVD event was defined as a composite of cardiovascular death, MI, and stroke. The deaths up until December 31, 2011 were confirmed by matching the information to the death records. For this, death certificates in the National Statistical Office were identified by using identification numbers that were assigned to the subjects at birth. The abstractors coded the causes of death according to the ICD-10. 15 These recorded underlying causes were used in the present study. The deaths in the present study were classified as cardiovascular if ICD-10 codes I00-99 and R96 were recorded and as noncardiovascular when other ICD-10 codes were recorded. 16, 17 MI and stroke were defined by using the hospital discharge databases of the HIRA (ICD-10 codes I21-22 and I60-69).
Statistical Analysis
The population was classified randomly into 2 cohorts. The prediction model was developed in the train cohort (n=45 914) and tested in the validation cohort (n=11 479). In subjects with multiple events, the first event was considered to be the component of the composite outcome. The statistical analyses were performed using the time of first event.
To develop a prediction model that estimates the CVD event rate, a Cox proportional hazards model was used. The candidate prognostic variables are presented in Table 1 . To select the prognostic factors, a random survival forest method was used. In this method, all covariates are included at first, after which the importance scores are computed. 18 The clinically or statistically less-meaningful variables (such as variables that have a contradictory coefficient sign) are excluded one by one during the model-building process. Thereafter, several candidate models for CVD events were developed and compared.
To avoid multicollinearity between the selected variables, the variation inflation factor was computed. Multicollinearity was deemed to be present if this factor was ≥5. Sometimes variables can be grouped on the basis of subject knowledge. We have created 2 index variables representing patients' cholesterols and blood pressures. 19 Because we had expected that low-density cholesterol, high-density cholesterol, and total cholesterol are highly correlated and that systolic and diastolic pressures are highly correlated as well, we created indices for the cholesterol and the blood pressure as it follows. For the standardized covariate values (=[original value−sample mean]/SD), we fitted a univariate regression with survival time outcome and used the estimated regression coefficient for the index weight. 20 can be used to examine the linearity assumption of predictors in the multivariable model. Furthermore, although overfitting may not be a problem in this large cohort, possible overfitting was assessed by calculating a slope shrinkage estimate: if its value exceeded <0.85, the model was considered to be overfitted. In addition, the discrimination and calibration abilities of the model were measured by calculating the concordance index (C-index) and the Hosmer−Lemeshow type statistic (Nam and D'Agostino χ 2 statistic). 21 The best-fitting model was formulated on the basis of the least loss of predictive ability with clinical simplification, compared with the maximal-fitting model using all variables based on the importance score table. After fitting several candidate models, the Akaike Information Criterion values were also determined. To compare the performances of the models to the Framingham risk models, the models were built using the published equations and the net reclassification index and integrated discrimination improvement were estimated. 9, 10, 22 To develop a user-friendly nomogram, the rms package developed by Harrell in R software version 2.15.1 was used. 23 All data analyses were performed using R software (version 2.15.1; R Foundation for Statistical Computing, Vienna, Austria). 24 All reported P values are 2-sided. A P value of <0.05 was considered to indicate statistical significance.
Results
Population Characteristics and Outcomes
The baseline characteristics of the study population are shown in 
CVD Predictors and Risk Model Development
Thirty-one potential variables were evaluated in the train cohort for model inclusion. In univariate analysis, age was the best single predictor of CVD events (hazards ratio, 1.086; 95% CI, 1.075-1.097; P<0.001). The variable importance scores were computed by using the random forest method ( Table I in the Data Supplement). Variables with relative importance scores >0.1 were selected as possible CVD event determinants. Age had the highest importance score. Possible predictive models for CVD events were gradually developed by using the variables and their C-index (95% CI) and Akaike Information Criterion values were calculated ( Table  II in the Data Supplement). The best-fitting predictive model was model 11, which used 11 variables, namely, age, diabetes mellitus, hypertension, current smoking, family history of CHD, white blood cell (WBC) count, creatinine level, glycohemoglobin level, atrial fibrillation, and blood pressure and cholesterol indices ( Table 2 ). For the CVD events, the C-index and Akaike Information Criterion were 0.757 (0.726-0.788) and 7207.
Risk Model Validation
The performance of the models in the validation cohort is summarized in Table III in the Data Supplement. When the bestfitting predictive model was tested in the validation cohort, it performed well in terms of discrimination and calibration abilities for CVD events (C-index =0.760 [0.693-0.828] and Nam and D'Agostino χ 2 statistic =0.001 for 3 years; C-index =0.782 [0.719-0.846] and Nam and D'Agostino χ 2 statistic =1.037 for 5 years; Table 3 ). The Nam and D'Agostino χ 2 statistic of the best-fitting model was smaller than the other model statistics, which indicates a better match between the predicted and observed risks.
Risk Reclassification and Comparison With the Framingham Risk Model
Several individuals who were reclassified by the different risk models into different risk groups are listed in Table IV in the Data Supplement. Depending on the model, the risk of subject 5 differed by ≤19%.
The Framingham risk model for CVD showed comparable discriminating and calibrating abilities in the train cohort (Table 2 ) and the validation cohort (Table 3) . When assessed by the net reclassification index and integrated discrimination improvement, a comparable predictive ability between the best-fitting model and Framingham model for CVD was also observed ( 
Clinical Application
A prognostic nomogram that estimated the CVD event risk was developed ( Figure 2 ). Points were assigned for age, diabetes mellitus, hypertension, current smoking, family history of CHD, WBC count, creatinine, glycohemoglobin, atrial fibrillation, blood pressure index, and cholesterol index and a line was drawn upward from the corresponding values to the "points" line. The sum of these 11 points, which plotted 
Discussion
A CVD risk prediction model was developed in this study with 57 393 asymptomatic South Korean individuals who were followed up for a median of 3.1 (interquartile range, 1.9-4.3) years. The main findings of this study were (1) our asymptomatic Korean population had a low incidence of CVD events, (2) of all the risk factors, age associated most strongly with CVD events, (3) a standard risk model developed in the Western population was also valid in our Korean population, and (4) the new model, which was based on both standard risk factors and biomarkers, showed a feasible model performance for predicting CVD events in this Korean population. One strength of this study was that it focused on Asian population. By contrast, most other CVD risk prediction models have not been adequately tested in this ethnicity. Another strength was that CVD events were detected using the National Statistical Office and HIRA databases in Korea: these governmental and quasigovernmental organizations provide quality-controlled and reliable data. This study design thus allowed the incidence of any CVD events and the factors that contribute to these events independently to be determined in a comprehensive and reliable manner. In addition, we could conduct this study at the minimal expense of cost ($15 000) by When all variables based on the importance score table were included, the maximum C-index was 0.771 (95% confidence interval, 0.739-0.802) and the Akaike information criterion was 7221.
Higher the use of pre-existing database and support of governmental and quasigovernmental organizations. The participants of our study generally had a lower CVD risk (annual CVD event rate of 0.3%) than the cohorts assessed in previous studies in which CVD risk models were developed (annual event rates =0.3%-1.1%, 9, 11, 12, 25, 26 although there were differences in the study end points). This discrepancy may reflect the fact that the subjects in our study were much younger (mean 42 years in this study versus mean 49-63 years in other studies) and had lower blood pressure, total cholesterol levels, and hsCRP levels than other study participants. [9] [10] [11] [12] Interestingly, in the present cohort, there were more strokes than MI events. This finding was in line with previous studies showing that stroke-induced death and disability occurs more frequently in Asian populations than in Western populations. 1, 27 The important covariates in our risk model were age, diabetes mellitus, hypertension, current smoking, family history of CHD, WBC, creatinine, glycohemoglobin, atrial fibrillation, blood pressure, and cholesterol. Among them, age was the strongest predictive determinant of CVD events. This is not surprising because aging has a remarkable effect on the heart and arterial system and markedly elevates the risk of CVD, such as atherosclerosis, hypertension, stroke, MI, and atrial fibrillation. 28, 29 By contrast, the contribution of the other risk factors to CVD risk prediction was much smaller.
To increase the predictive ability of our risk model, blood pressure and cholesterol were expressed as indices rather than as categories because this prevented potential multicollinearity caused by a correlation between cholesterol and blood pressure. In the final model, the cholesterol and blood pressure indices associated independently with CVD events. In addition to the standard Framingham risk factors, 9, 10 CVD events also associated significantly with a family history of CHD, WBC count, creatinine level, glycohemoglobin level, and atrial fibrillation in the present study. Although our health questionnaire did not specifically ask whether the family member with CHD developed CHD prematurely, a simple family history of CHD contributes significantly to long-term CVD events as a prior study. 30 This finding was also in line with previous studies. 4, 31 Of the biomarkers that were assessed, WBC count (an inflammatory marker) 31 was significantly associated with CVD risk in our model. However, hsCRP level did not associate with CVD events. This may reflect, at least partly, the low prevalence of high hsCRP (defined as ≥2 mg/dL) in our population compared with the prevalences in other cohorts. 11, 12, 32 Alternatively, the standard biomarkers used in the risk model for the Western population may not associate independently with CVD events in Asian populations. The degree of glycemic control and renal function and atrial fibrillation were also predictive factors in our model. This has also been observed in other studies. 11, 12, 33 However, neither physical activity nor educational level added further prognostic information in terms of CVD risk in our cohort. 11 This may reflect, at least partly, the characteristics of our study population: all study subjects volunteered for their medical checkup. East Asian populations have been known to have specific characteristics of higher stroke mortality and incidence but lower CHD mortality and incidence than other Asian or Western populations. 1, 3, 27 Also, East Asian populations have similar characteristics of risk factors for CVD, such as higher prevalence of hypertension accompanied by high salt intake, higher smoking rate, lower serum total cholesterol with lower fat intake, and increasing prevalence of obesity and diabetes mellitus by rapid and early-phase westernization, compared with other populations. 3 Therefore, we think that our risk model might be applicable to East Asian populations, such as Japanese and Chinese populations. In addition, interestingly, the Framingham risk model (which was created in a Western cohort) performed as well as our risk model in our Korean cohort. This suggests that the CVD risk factors in the Framingham risk model are true for all global populations, regardless of genetic or lifestyle differences. These findings highlight the importance of global collaborative efforts that seek to prevent cardiovascular events. An example of such useful international studies is the study by Yusuf et al 34 , which showed that, globally, most cases of premature heart attack can be prevented by approaches that are based on similar principles.
Our study had several limitations. First, our cohort had a lower CVD risk than the cohorts in other risk model studies. This reflects the fact that all subjects went to the hospital for the general health examination and were asymptomatic. Therefore, this study may be weaker in methodology than previous studies using randomly sampled populations. Second, because this study was conducted in a single center, there was a possibility that study participants were a homogeneous cohort. Third, in the Cox proportional hazards model, the relative risk is constant across the time interval. Therefore, it would be more robust to the estimating time point than other parametric models whose relative risks also depend on time. However, to facilitate the accessibility to clinicians, we projected a risk prediction model to 5 years. Because the follow-up period was limited, this model may have a problem to completely predict the 5-year clinical outcomes. In addition, it needs to be extended to develop a 10-year risk model like the other risk models that have been developed to date in the following researches. Fourth, although novel inflammation, hemostasis, thrombosis, and oxidative stress biomarkers have been proposed as alternatives for detecting individuals at high risk of CVD events, 35 the analysis of these biomarkers in the present study was limited. In the case of hsCRP, the database only indicated whether the subjects were >2 mg/dL cut-off point. Moreover, apolipoprotein A1, apolipoprotein B, fibrinogen, and homocysteine measurements were only available in ≈10% of the study participants and thus were not included in the analysis. Therefore, other large studies to evaluate the incremental usefulness of possible biomarkers were needed. Fifth, although we used the database by governmental and quasigovernmental organizations, there was a possibility that these data could not have fully reflected outcomes. In addition, because the discrepancy between causes of death and death certificates has been noted, 36, 37 there was a potential for classification bias. Finally, the study only included the Korean population. Thus, it was not possible to compare different races in terms of their CVD event risks.
Conclusions
The present study yielded a risk model that allows the global risk of CVD events in an asymptomatic Korean population to be estimated. This model may be useful for identifying East Asian individuals at high risk of CVD. However, this proposed CVD risk model should be validated by additional studies.
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